Kozak & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.8K Buy
397
+6
+2% +$565 0.01% 179
2026
Q1
$46.9K Buy
391
+2
+0.5% +$247 0.01% 153
2025
Q4
$49.5K Sell
389
-775
-67% -$101K 0.01% 148
2025
Q3
$138K Buy
1,164
+4
+0.3% +$605 0.03% 95
2025
Q2
$184K Sell
1,160
-33
-3% -$5.23K 0.04% 83
2025
Q1
$180K Buy
1,193
+36
+3% +$5.99K 0.04% 79
2024
Q4
$189K Sell
1,157
-19
-2% -$3.4K 0.04% 83
2024
Q3
$229K Buy
1,176
+22
+2% +$4.05K 0.05% 73
2024
Q2
$203K Buy
1,154
+3
+0.3% +$499 0.05% 73
2024
Q1
$200K Buy
1,151
+2
+0.2% +$375 0.05% 77
2023
Q4
$222K Hold
1,149
0.07% 74
2023
Q3
$202K Hold
1,149
0.07% 80
2023
Q2
$196K Hold
1,149
0.08% 81
2023
Q1
$191K Hold
1,149
0.09% 84
2022
Q4
$168K Hold
1,149
0.08% 86
2022
Q3
$168K Sell
1,149
-30
-3% -$5.01K 0.11% 83
2022
Q2
$203K Hold
1,179
0.14% 73
2022
Q1
$223K Hold
1,179
0.14% 74
2021
Q4
$223K Buy
1,179
+30
+3% +$6.57K 0.14% 74
2021
Q3
$248K Buy
+1,149
New +$232K 0.15% 69

Other funds holding ZTS

Kozak & Associates's ZTS Position: Q2 2026 in Review

Kozak & Associates increased its Zoetis (ZTS) stake by 1.5% in Q2 2026, buying an estimated $565 and bringing the position to 397 shares worth $28.8K. The position accounts for 0.01% of the portfolio, ranked #179.

Kozak & Associates first reported a position in ZTS in Q3 2021 and has held it in 20 quarters since. The position peaked at $248K in Q3 2021. 271 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Kozak & Associates held 397 shares of Zoetis worth $28.8K as of Q2 2026.
  • Kozak & Associates bought 6 Zoetis shares in Q2 2026, an estimated $565.
  • Zoetis made up 0.01% of Kozak & Associates's portfolio in Q2 2026, its #179 holding.
  • Kozak & Associates first reported a position in Zoetis in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's Zoetis position peaked at $248K in Q3 2021.
  • 271 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.